Seeking AlphaThu, 30 Apr 2026 08:21:47 GMTTelix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX597 TranscriptTLX-2.76%
BenzingaFri, 10 Apr 2026 13:15:02 GMTTelix Seeks Reset With FDA Filing While Sales Growth Holds SteadyTLX-2.76%
Seeking AlphaWed, 08 Apr 2026 13:20:52 GMTTelix Pharmaceuticals: Solid Q1 As Pipeline And PSMA Franchise Drive OutlookTLX-2.76%
Seeking AlphaTue, 17 Mar 2026 23:42:20 GMTTelix Pharmaceuticals Limited (TLX) Discusses Revenue Growth, Prostate Cancer Imaging Portfolio, and Expansion into Brain and Kidney Cancer TranscriptTLX-2.76%
Seeking AlphaTue, 10 Mar 2026 04:47:58 GMTTelix Pharmaceuticals Limited (TLX) Discusses ProstACT Global Phase 3 Study Part 1 Results and Safety Profile TranscriptTLX-2.76%
Seeking AlphaThu, 05 Mar 2026 05:42:17 GMTTelix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer TranscriptTLX-2.76%
Seeking AlphaMon, 02 Mar 2026 03:00:48 GMTTelix Pharmaceuticals: Scope Of Company Beyond Radio Antibody-Drug Conjugate TLX591-TxTLX-2.76%
The Motley FoolThu, 26 Feb 2026 10:15:00 GMT1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational WealthTLX-2.76%
Seeking AlphaFri, 20 Feb 2026 07:44:56 GMTTelix Pharmaceuticals Limited (TLX) Q4 2025 Earnings Call TranscriptTLX-2.76%
